- Home
- SMJF vs HURA Comparison
SMJF vs HURA Comparison
Compare SMJF & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SMJF | HURA |
|---|---|---|
| Founded | 1988 | 2009 |
| Country | Singapore | United States |
| Employees | N/A | 19 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.8M | 87.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SMJF | HURA |
|---|---|---|
| Price | $3.27 | $2.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 967.1K | ★ 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $68.08 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $0.41 |
| 52 Week High | $5.70 | $4.41 |
Technical Indicators
Market Signals| Indicator | SMJF | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 74.62 |
| Support Level | $0.82 | $1.56 |
| Resistance Level | $5.65 | $2.16 |
| Average True Range (ATR) | 0.52 | 0.21 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 81.68 | 87.61 |
Price Performance
Historical ComparisonAbout SMJF SMJ International Holdings Inc. Class A Ordinary Shares
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.